dihexa clinical trial in Trials: What We've Learned So Far dihexa human clinical trial dihexa

Updated July 25, 2026: The FDA peptide vote 2026 is complete

Understanding these interactions remains an important focus of laboratory research, with BPC-157 continuing to feature in studies exploring molecular signalling, tissue architecture and physiological regulation

Common B12 deficiency symptoms include: Persistent fatigue and weakness Tingling or numbness in hands and feet Memory problems and difficulty concentrating Mood changes like irritability or depression Dizziness and balance issues Pale skin or yellowing of eyes Sore, red tongue Who is Most at Risk for B12 Deficiency

About 50% of people with PA test negative on IFA test